Abstract
Prophylaxis with palivizumab has been shown to decrease hospitalizations in at-risk infants. Compliance was higher with a home-based rather than a clinic-based system and was associated with decreased hospitalizations and unscheduled medical visits. Home-based delivery of respiratory syncytial virus prophylaxis may be more efficacious in preventing disease through increased compliance and decreased exposure of the high-risk infant to the clinic environment.
| Original language | English |
|---|---|
| Pages (from-to) | 175-176 |
| Number of pages | 2 |
| Journal | Pediatric Infectious Disease Journal |
| Volume | 27 |
| Issue number | 2 |
| DOIs | |
| State | Published - Feb 2008 |
| Externally published | Yes |
Keywords
- Compliance
- Immunoprophylaxis
- Prematurity
- Respiratory syncytial virus